Related references
Note: Only part of the references are listed.Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis
Darren K. McGuire et al.
JAMA CARDIOLOGY (2021)
Variability of risk factors and diabetes complications
Antonio Ceriello et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
Benedetta Maria Bonora et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Glycemic variability: adverse clinical outcomes and how to improve it?
Zheng Zhou et al.
CARDIOVASCULAR DIABETOLOGY (2020)
HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes
M. V. Pinto et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications
Eleftheria Papachristoforou et al.
JOURNAL OF DIABETES RESEARCH (2020)
Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring
Yuji Kawaguchi et al.
DIABETES THERAPY (2020)
The Association between Serum Uric Acid and Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus: A Multicenter Nationwide Cross-Sectional Study
Wisit Kaewput et al.
KOREAN JOURNAL OF FAMILY MEDICINE (2020)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jae Hyun Bae et al.
SCIENTIFIC REPORTS (2019)
The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes
Francesca Iannantuoni et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Improvement in Neuropathy Outcomes With Normalizing HbA(1c) in Patients With Type 2 Diabetes
Fukashi Ishibashi et al.
DIABETES CARE (2019)
Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
Jingyi Lu et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
Kyung Ae Lee et al.
DIABETES & METABOLISM JOURNAL (2018)
The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes
Helena W. Rodbard et al.
DIABETES CARE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mediators of diabetic neuropathy: is hyperglycemia the only culprit?
Anna Grisold et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes
Antonio Ceriello et al.
DIABETES OBESITY & METABOLISM (2017)
Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats
Shoji Takakura et al.
LIFE SCIENCES (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure
Fukashi Ishibashi et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Solomon Tesfaye et al.
DIABETES CARE (2010)
Relationships between Glucose Variability and Conventional Measures of Glycemic Control in Continuously Monitored Patients with Type 2 Diabetes
K. -D. Kohnert et al.
HORMONE AND METABOLIC RESEARCH (2009)
Share Paper
